By Dr Sunil Badve

Journal articles

Lo C; Toyama T; Hirakawa Y; Jun M; Cass A; Hawley C; Pilmore H; Badve S; Perkovic V; Zoungas S, 2015, 'Insulin and glucose-lowering agents for treating people with diabetes and chronic kidney disease', Cochrane Database of Systematic Reviews

Badve SV; Paul SK; Klein K; Clayton PA; Hawley CM; Brown FG; Boudville N; Polkinghorne KR; McDonald SP; Johnson DW, 2014, 'The association between body mass index and mortality in incident dialysis patients', Plos One, 9, http://dx.doi.org/10.1371/journal.pone.0114897

Mallett A; Tang W; Clayton PA; Stevenson S; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Campbell SB; Johnson DW, 2014, 'End-stage kidney disease due to alport syndrome: Outcomes in 296 consecutive Australia and New Zealand dialysis and transplant registry cases', Nephrology Dialysis Transplantation, 29, pp. 2277 - 2286, http://dx.doi.org/10.1093/ndt/gfu254

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Clayton P; Johnson DW, 2014, 'Peritoneal dialysis outcomes after temporary haemodialysis transfer for peritonitis', Nephrology Dialysis Transplantation, 29, pp. 1940 - 1947, http://dx.doi.org/10.1093/ndt/gfu050

Johnson DW; Pascoe E; Badve SV; Dalziel K; Cass A; Clarke P; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Scaria A; Walker R; Vergara LA; Hawley CM, 2014, 'A RANDOMIZED, PLACEBO-CONTROLLED TRIAL OF PENTOXIFYLLINE ON ERYTHROPOIESIS STIMULATING AGENT RESISTANCE IN ANAEMIC PATIENTS WITH CHRONIC KIDNEY DISEASE - THE HERO TRIAL', NEPHROLOGY, 19, pp. 29 - 29, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700047&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Roberts MA; Palmer SC; Hiremath SS; Hawley CM; Perkovic V; Whalley GA; Strippoli GFM; Johnson DW, 2014, 'INTERVENTIONS FOR REDUCTION OF LEFT VENTRICULAR MASS IN CHRONIC KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS', NEPHROLOGY, 19, pp. 32 - 32, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700056&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; De Zoysa J; Isbel NM; Mctaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW, 2014, 'MICROBIOLOGICAL RESULTS OF THE HONEYPOT STUDY - SECONDARY ANALYSIS OF A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS', NEPHROLOGY, 19, pp. 30 - 30, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000339715700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bose B; Badve SV; Hiremath SS; Boudville N; Brown FG; Cass A; De Zoysa JR; Fassett RG; Faull R; Harris DC; Hawley CM; Kanellis J; Palmer SC; Perkovic V; Pascoe EM; Rangan GK; Walker RJ; Walters G; Johnson DW, 2014, 'Effects of uric acid-lowering therapy on renal outcomes: A systematic review and meta-analysis', Nephrology Dialysis Transplantation, 29, pp. 406 - 413, http://dx.doi.org/10.1093/ndt/gft378

Johnson DW; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM, 2014, 'Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): A randomised trial', Lancet Infectious Diseases, 14, pp. 23 - 30, http://dx.doi.org/10.1016/S1473-3099(13)70258-5

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis', Cochrane Database of Systematic Reviews, 2014, http://dx.doi.org/10.1002/14651858.CD007554.pub2

Cho Y; Johnson DW; Craig JC; Strippoli GFM; Badve SV; Wiggins KJ, 2014, 'Biocompatible dialysis fluids for peritoneal dialysis.', The Cochrane database of systematic reviews, 3

Badve SV; Johnson DW, 2014, 'Chronic kidney disease: haemodialysis catheter care in practice.', Nature Reviews Nephrology, 10, pp. 131 - 133, http://dx.doi.org/10.1038/nrneph.2014.3

Morrish AT; Hawley CM; Johnson DW; Badve SV; Perkovic V; Reidlinger DM; Cass A, 2014, 'Establishing a clinical trials network in nephrology: Experience of the Australasian Kidney Trials Network', Kidney International, 85, pp. 23 - 30, http://dx.doi.org/10.1038/ki.2013.391

Lan PG; Johnson DW; McDonald SP; Boudville N; Borlace M; Badve SV; Sud K; Clayton PA, 2014, 'The association between peritoneal dialysis modality and peritonitis', Clinical Journal of the American Society of Nephrology, 9, pp. 1091 - 1097, http://dx.doi.org/10.2215/CJN.09730913

Tang W; Cho Y; Hawley CM; Badve SV; Johnson DW, 2014, 'The role of monitoring Gentamicin levels in patients with gram-negative peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 34, pp. 219 - 226, http://dx.doi.org/10.3747/pdi.2012.00318

Zhang L; Pascoe EM; Badve SV; Cass A; Clarke P; Coombes JS; Ferrari P; Mcdonald SP; Morrish AT; Pedagogos E; Perkovic V; Reidlinger D; Scaria A; Walker R; Vergara LA; Hawley CM; Johnson DW, 2014, 'THE EFFECT OF PENTOXIFYLLINE ON OXIDATIVE STRESS MARKERS: SUBSTUDY OF THE HERO TRIAL', NEPHROLOGY, 19, pp. 35 - 35

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Bannister KM; Clayton PA; Johnson DW, 2013, 'Association of biocompatible peritoneal dialysis solutions with peritonitis risk, treatment, and outcomes', Clinical Journal of the American Society of Nephrology, 8, pp. 1556 - 1563, http://dx.doi.org/10.2215/CJN.12361212

Johnson D; Badve S; Pascoe E; Beller E; Cass A; Clark C; De Zoysa J; Mctaggart S; Isbel N; Morrish A, 2013, 'A RANDOMISED, CONTROLLED TRIAL OF EXIT SITE APPLICATION OF MEDIHONEY FOR THE PREVENTION OF CATHETER-ASSOCIATED INFECTIONS IN PD PATIENTS - HONEYPOT STUDY', NEPHROLOGY, 18, pp. 27 - 27, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000323453000049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Beller EM; Cass A; Francis DP; Hawley C; Macdougall IC; Perkovic V; Johnson DW, 2013, 'Interventions for erythropoietin-resistant anaemia in dialysis patients', Cochrane Database of Systematic Reviews, 2013, http://dx.doi.org/10.1002/14651858.CD006861.pub3

Cho Y; Johnson DW; Badve S; Craig JC; Strippoli GFK; Wiggins KJ, 2013, 'Impact of icodextrin on clinical outcomes in peritoneal dialysis: A systematic review of randomized controlled trials', Nephrology Dialysis Transplantation, 28, pp. 1899 - 1907, http://dx.doi.org/10.1093/ndt/gft050

Pascoe EM; Lo S; Scaria A; Badve SV; Beller EM; Cass A; Hawley CM; Johnson DW, 2013, 'The honeypot randomized controlled trial statistical analysis plan', Peritoneal Dialysis International, 33, pp. 426 - 435, http://dx.doi.org/10.3747/pdi.2012.00310

Tang W; Bose B; Mcdonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; Peh CA; Johnson DW, 2013, 'The outcomes of patients with ESRD and ANCA-associated Vasculitis in Australia and New Zealand', Clinical Journal of the American Society of Nephrology, 8, pp. 773 - 780, http://dx.doi.org/10.2215/CJN.08770812

Tang W; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'End-stage renal failure due to amyloidosis: Outcomes in 490 ANZDATA registry cases', Nephrology Dialysis Transplantation, 28, pp. 455 - 461, http://dx.doi.org/10.1093/ndt/gfs492

Tang W; Mcdonald SP; Hawley CM; Badve SV; Boudville NC; Brown FG; Clayton PA; Campbell SB; De Zoysa JR; Johnson DW, 2013, 'Anti-glomerular basement membrane antibody disease is an uncommon cause of end-stage renal disease', Kidney International, 83, pp. 503 - 510, http://dx.doi.org/10.1038/ki.2012.375

Krishnasamy R; Badve SV; Hawley CM; McDonald SP; Boudville N; Brown FG; Polkinghorne KR; Bannister KM; Wiggins KJ; Clayton P; Johnson DW, 2013, 'Daily variation in death in patients treated by long-term dialysis: Comparison of in-center hemodialysis to peritoneal and home hemodialysis', American Journal of Kidney Diseases, 61, pp. 96 - 103, http://dx.doi.org/10.1053/j.ajkd.2012.07.008

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2013, 'Effects of climatic region on peritonitis risk, microbiology, treatment, and outcomes: A multicenter registry study', Peritoneal Dialysis International, 33, pp. 75 - 85, http://dx.doi.org/10.3747/pdi.2011.00317

Cho Y; Johnson DW; Badve SV; Craig JC; Strippoli GFM; Wiggins KJ, 2013, 'The impact of neutral-pH peritoneal dialysates with reduced glucose degradation products on clinical outcomes in peritoneal dialysis patients', Kidney International, 84, pp. 969 - 979, http://dx.doi.org/10.1038/ki.2013.190

Tang W; Mohandas J; McDonald SP; Hawley CM; Badve SV; Boudville N; Brown FG; Clayton PA; Wiggins KJ; Bannister KM; Campbell SB; Johnson DW, 2012, 'End-stage kidney disease due to haemolytic uraemic syndrome - Outcomes in 241 consecutive ANZDATA registry cases', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-164

Cho Y; Badve SV; Hawley CM; Wiggins K; Johnson DW, 2012, 'Biocompatible peritoneal dialysis fluids: Clinical outcomes', International Journal of Nephrology, 2012, http://dx.doi.org/10.1155/2012/812609

Johnson DW; Clayton P; Cho Y; Badve SV; Hawley CM; McDonald S; Boudville N; Wiggins KJ; Bannister K; Brown F, 2012, 'Weekend compared with weekday presentations of peritoneal dialysis-associated peritonitis', Peritoneal Dialysis International, 32, pp. 516 - 524, http://dx.doi.org/10.3747/pdi.2011.00169

Lee A; Killen J-P; Hawley C; Jeffries J; Equinox K; Johnson D; Campbell S; Isbel N; Mudge D; Badve S; Van Eps C, 2012, 'NXSTAGE QUEENSLAND HEALTH PILOT PROGRAM THE EARLY AUSTRALIAN NXSTAGE EXPERIENCE: IS NXSTAGE REALLY THE NEXT STAGE IN HOME HAEMODIALYSIS?', NEPHROLOGY, 17, pp. 50 - 50, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400088&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Bose B; Mallett A; Badve SV; Johnson DW; Hawley C; Mudge D; Van Eps C; Campbell S; Isbel N, 2012, 'TWO CASES OF ATYPICAL HAEMOLYTIC UREMIC SYNDROME TREATED WITH ECULIZUMAB', NEPHROLOGY, 17, pp. 91 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000307544400246&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; M NB; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2012, 'The effects of living distantly from peritoneal dialysis units on peritonitis risk, microbiology, treatment and outcomes: A multi-centre registry study', BMC Nephrology, 13, http://dx.doi.org/10.1186/1471-2369-13-41

Mudge DW; Tan KS; Miles R; Johnson DW; Badve SV; Campbell SB; Isbel NM; Van Eps CL; Hawley CM, 2012, 'A randomized controlled trial of intravenous or oral iron for posttransplant anemia in kidney transplantation', Transplantation, 93, pp. 822 - 826, http://dx.doi.org/10.1097/TP.0b013e318248375a

Woditschka S; Palmieri D; Duchnowska R; Jassem J; Badve S; Sledge GW; Steeg PS, 2012, 'Overexpression of RAD51 promotes brain metastases from breast cancer', CANCER RESEARCH, 72, http://dx.doi.org/10.1158/1538-7445.AM2012-5306

Roberts MA; Pilmore HL; Tonkin AM; Garg AX; Pascoe EM; Badve SV; Cass A; Ierino FL; Hawley CM, 2012, 'Challenges in blood pressure measurement in patients treated with maintenance hemodialysis', American Journal of Kidney Diseases, 60, pp. 463 - 472, http://dx.doi.org/10.1053/j.ajkd.2012.04.026

Boudville N; Kemp A; Clayton P; Lim W; Badve SV; Hawley CM; McDonald SP; Wiggins KJ; Bannister KM; Brown FG; John DW, 2012, 'Recent peritonitis associates with mortality among patients treated with peritoneal dialysis', Journal of the American Society of Nephrology, 23, pp. 1398 - 1405, http://dx.doi.org/10.1681/ASN.2011121135

Thirugnanasambathan T; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton P; Johnson DW, 2012, 'Repeated peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 59, pp. 84 - 91, http://dx.doi.org/10.1053/j.ajkd.2011.06.018

Cho Y; Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Clayton PA; Johnson DW, 2012, 'Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-centre registry study.', Nephrology Dialysis Transplantation Official Publication of the European Dialysis and Transplant Association European Renal Association, 27, pp. 2028 - 2036, http://dx.doi.org/10.1093/ndt/gfr582

Badve SV; Hawley CM; McDonald SP; Brown FG; Boudville NC; Wiggins KJ; Bannister KM; Johnson DW, 2012, 'Use of aminoglycosides for peritoneal dialysis-associated peritonitis does not affect residual renal function', Nephrology Dialysis Transplantation, 27, pp. 381 - 387, http://dx.doi.org/10.1093/ndt/gfr274

Jun M; Badve SV; Hawley CM; Pilmore H; White S; Cass A; Perkovic V; Zoungas S, 2012, 'Glucose lowering therapies for chronic kidney disease and kidney transplantation (Protocol)', Cochrane Database of Systematic Reviews, http://dx.doi.org/10.1002/14651858.CD009966

Young V; Orazio L; Badve SV; Bates A; Johnson DW; Campbell KL, 2012, 'IMPACTS ON PROTEIN INTAKE IN PERITONEAL DIALYSIS PATIENTS', Kidney Research and Clinical Practice, 31, pp. A87 - A87, http://dx.doi.org/10.1016/j.krcp.2012.04.606

Toussaint ND; Pedagogos E; Tan SJ; Badve SV; Hawley CM; Perkovic V; Elder GJ, 2012, 'Phosphate in early chronic kidney disease: Associations with clinical outcomes and a target to reduce cardiovascular risk', Nephrology, 17, pp. 433 - 444, http://dx.doi.org/10.1111/j.1440-1797.2012.01618.x

Bose B; McDonald SP; Hawley CM; Brown FG; Badve SV; Wiggins KJ; Bannister KM; Boudville N; Clayton P; Johnson DW, 2011, 'Effect of dialysis modality on survival of hepatitis C-infected ESRF patients', Clinical Journal of the American Society of Nephrology, 6, pp. 2657 - 2661, http://dx.doi.org/10.2215/CJN.02200311

Badve SV; Roberts MA; Hawley CM; Cass A; Garg AX; Krum H; Tonkin A; Perkovic V, 2011, 'Effects of beta-adrenergic antagonists in patients with chronic kidney disease: A systematic review and meta-analysis', Journal of the American College of Cardiology, 58, pp. 1152 - 1161, http://dx.doi.org/10.1016/j.jacc.2011.04.041

Burke M; Hawley CM; Badve SV; McDonald SP; Brown FG; Boudville N; Wiggins KJ; Bannister KM; Johnson DW, 2011, 'Relapsing and recurrent peritoneal dialysis-associated peritonitis: A multicenter registry study', American Journal of Kidney Diseases, 58, pp. 429 - 436, http://dx.doi.org/10.1053/j.ajkd.2011.03.022

Badve SV; Brown F; Hawley CM; Johnson DW; Kanellis J; Rangan GK; Perkovic V, 2011, 'Challenges of conducting a trial of uric-acid-lowering therapy in CKD', Nature Reviews Nephrology, 7, pp. 295 - 300, http://dx.doi.org/10.1038/nrneph.2010.186

Agarwal R, 2011, 'Frequent versus Standard Hemodialysis', NEW ENGLAND JOURNAL OF MEDICINE, 364, pp. 975 - 976, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000288170300021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Badve SV; Hawley CM; Johnson DW, 2011, 'Frequent versus standard hemodialysis.', N Engl J Med, 364, pp. 975, http://dx.doi.org/10.1056/NEJMc1100105

Badve SV; Hawley CM; Johnson DW, 2011, 'Is the problem with the vehicle or the destination? Does high-dose ESA or high haemoglobin contribute to poor outcomes in CKD?', Nephrology, 16, pp. 144 - 153, http://dx.doi.org/10.1111/j.1440-1797.2010.01407.x

Back to profile page